Contemporary national utilization of extracorporeal cardiopulmonary resuscitation (ECPR) for out-of-hospital cardiac arrest.


Journal

Journal of cardiac surgery
ISSN: 1540-8191
Titre abrégé: J Card Surg
Pays: United States
ID NLM: 8908809

Informations de publication

Date de publication:
Apr 2022
Historique:
revised: 05 11 2021
received: 23 10 2021
accepted: 24 12 2021
pubmed: 14 2 2022
medline: 4 3 2022
entrez: 13 2 2022
Statut: ppublish

Résumé

The utilization of extracorporeal membrane oxygenation (ECMO) during cardiopulmonary resuscitation (ECPR) has demonstrated promising evidence for the management of out-of-hospital cardiac arrest (OHCA). We aim to describe contemporary utilization and predictors of survival of patients receiving ECPR for OHCA. The National Inpatient Sample (NIS) was queried to identify hospital discharge records of patients aged ≥18 years who underwent ECPR from 2012 to 2017. Patients with an International Classification of Diseases, Tenth Revision, Clinical Modification diagnosis of cardiac arrest, admitted urgently and placed on ECMO on Day 0 of hospitalization, were selected. Patients with a primary diagnosis indicative of veno-venous ECMO were excluded. Predictors of mortality were assessed using multivariable analyses. There were 1675 cases of ECPR, increasing from 185 cases in 2012 to 400 in 2017 (p < .001). Overall mortality was 63.3%, which remained stable over time (p = .441). Common diagnoses included ST-elevation myocardial infarction (39.1%), non-ST-elevation myocardial infarction (9.3%), and pulmonary embolism (13.7%). Percutaneous coronary intervention was performed in 495 patients (29.6%); coronary artery bypass grafting was performed in 125 patients (7.5%). In multivariable analysis, decreased age, female gender, and left ventricular (LV) decompression were associated with reduced mortality. Utilization of ECPR is increasing nationally with stable mortality rates. Younger age, female gender, and utilization of LV decompression were associated with increased survival.

Identifiants

pubmed: 35152455
doi: 10.1111/jocs.16307
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

818-824

Informations de copyright

© 2022 Wiley Periodicals LLC.

Références

Kalra R, Kosmopoulos M, Goslar T, Raveendran G, Bartos JA, Yannopoulos D. Extracorporeal cardiopulmonary resuscitation for cardiac arrest. Curr Opin Crit Care. 2020;26(3):228-235.
Hadaya J, Dobaria V, Aguayo E, et al. National trends in utilization and outcomes of extracorporeal support for in- and out-of-hospital cardiac arrest. Resuscitation. 2020.
Patel JK, Meng H, Qadeer A, Parikh PB. Impact of extracorporeal membrane oxygenation on mortality in adults with cardiac arrest. Am J Cardiol. 2019;124(12):1857-1861.
Patel K, Doshi R, Decter D, Shah J, Meraj P. Trends in the utilization and in-hospital outcomes when using mechanical circulatory support devices for stable chronic total occlusion treated with percutaneous coronary intervention. Eur J Intern Med. 2019;59:e11-e13.
Patel NJ, Patel N, Bhardwaj B, et al. Trends in utilization of mechanical circulatory support in patients hospitalized after out-of-hospital cardiac arrest. Resuscitation. 2018;127:105-113.
Richardson AS, Schmidt M, Bailey M, Pellegrino VA, Rycus PT, Pilcher DV. ECMO Cardio-Pulmonary Resuscitation (ECPR), trends in survival from an international multicentre cohort study over 12-years. Resuscitation. 2017;112:34-40.
Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96(1):102-109.
Stub D, Bernard S, Pellegrino V, et al. Refractory cardiac arrest treated with mechanical CPR, hypothermia, ECMO and early reperfusion (the CHEER trial). Resuscitation. 2015;86:88-94.
Sun T, Guy A, Sidhu A, et al. Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) for emergency cardiac support. J Crit Care. 2018;44:31-38.
Khera R, Spertus JA, Starks MA, et al. Administrative codes for capturing in-hospital cardiac arrest. JAMA Cardiol. 2017;2(11):1275-1277.
Khera R, Krumholz HM. With great power comes great responsibility: big data research from the national inpatient sample. Circ Cardiovasc Qual Outcomes. 2017;10(7).
Yoshida T, Fujitani S, Wakatake H, et al. Exploratory observational study of extracorporeal cardiopulmonary resuscitation for nonshockable out-of-hospital cardiac arrest occurring after an emergency medical services arrival: SOS-KANTO 2012 Study Report. J Emerg Med. 2020.
Desai SR, Hwang NC. Strategies for left ventricular decompression during venoarterial extracorporeal membrane oxygenation-a narrative review. J Cardiothorac Vasc Anesth. 2020;34(1):208-218.
Bhatia M, Kumar PA. Pro: venoarterial extracorporeal membrane oxygenation should always include placement of a left ventricular vent. J Cardiothorac Vasc Anesth. 2019;33(4):1159-1162.
Xie A, Forrest P, Loforte A. Left ventricular decompression in veno-arterial extracorporeal membrane oxygenation. Ann Cardiothorac Surg. 2019;8(1):9-18.
Truby LK, Takeda K, Mauro C, et al. Incidence and implications of left ventricular distention during venoarterial extracorporeal membrane oxygenation support. ASAIO J. 2017;63(3):257-265.
Tonna JE, Johnson NJ, Greenwood J, et al. Practice characteristics of Emergency Department extracorporeal cardiopulmonary resuscitation (eCPR) programs in the United States: the current state of the art of Emergency Department extracorporeal membrane oxygenation (ED ECMO). Resuscitation. 2016;107:38-46.
Russo JJ, Aleksova N, Pitcher I, et al. Left ventricular unloading during extracorporeal membrane oxygenation in patients with cardiogenic shock. J Am Coll Cardiol. 2019;73(6):654-662.
Patel SM, Lipinski J, Al-Kindi SG, et al. Simultaneous venoarterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with impella is associated with improved outcomes in refractory cardiogenic shock. ASAIO J. 2019;65(1):21-28.
Wang L, Xing Z. Short-term outcomes of intra-aortic balloon pump combined with venoarterial extracorporeal membrane oxygenation: a systematic review and meta-analysis. Artif Organs. 2019;43(6):561-568.

Auteurs

Michael A Catalano (MA)

Division of Cardiac Surgery, Department of Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.

Stevan Pupovac (S)

Division of Cardiovascular and Thoracic Surgery, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA.

Frank Manetta (F)

Division of Cardiovascular and Thoracic Surgery, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA.

Kevin F Kennedy (KF)

Department of Cardiology, Saint Luke's Mid America Heart Institute and University of Missouri-Kansas City School of Medicine, Kansas City, Missouri, USA.

Alan Hartman (A)

Division of Cardiovascular and Thoracic Surgery, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA.

Pey-Jen Yu (PJ)

Division of Cardiovascular and Thoracic Surgery, Zucker School of Medicine at Hofstra/Northwell, Manhasset, New York, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH